Scheibenbogen, C., Allgäuer, T. W., Hofmann, U., Max, R., & Schadendorf, D. (2000). Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma. Journal of immunotherapy, 23(2), .
Chicago Style (17th ed.) CitationScheibenbogen, Carmen, Thomas W. Allgäuer, Udo Hofmann, Regina Max, and Dirk Schadendorf. "Phase 2 Trial of Vaccination with Tyrosinase Peptides and Granulocyte-macrophage Colony-stimulating Factor in Patients with Metastatic Melanoma." Journal of Immunotherapy 23, no. 2 (2000).
MLA (9th ed.) CitationScheibenbogen, Carmen, et al. "Phase 2 Trial of Vaccination with Tyrosinase Peptides and Granulocyte-macrophage Colony-stimulating Factor in Patients with Metastatic Melanoma." Journal of Immunotherapy, vol. 23, no. 2, 2000.